journal article·2023-12Open access

Enhancing BMP-2-mediated osteogenesis with a synthetic heparan sulfate mimetic

Raymond A.A. Smith, Xiaoman Luo, Xiaohua Lu, Tuan Chun Tan, Bach Q. Le, Olga V. Zubkova, Peter C. Tyler, Victor Nurcombe, Simon M. Cool

Abstract

Bone morphogenetic protein 2 (BMP-2) is an osteoinductive protein and a potent inducers of bone formation, playing an essential role during bone fracture repair. Heparan sulfate (HS), a highly charged and linear polysaccharide, is known to interact with and enhance BMP-2 bioactivity. Despite showing potential as a potent adjuvant of the endogenous bone healing response, commercially available HS is derived from animal sources which are less desirable when considering translation into the clinic. In the present study, we screen twenty glycomimetics against BMP-2 to determine if fully synthetic analogues of HS can enhance the bioactivity of BMP-2 in vitro and bone healing in vivo. We found that a four-armed dendrimer harboring oversulfated maltose residues could bind BMP-2 with high affinity, enhance BMP-2 bioactivity in vitro and enhance bone regeneration in vivo. These data suggest fully synthetic glycomimetics are viable alternatives to naturally derived HS and offer an attractive alternative for clinical translation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Proteoglycans and glycosaminoglycans research · Periodontal Regeneration and Treatments · Connective tissue disorders research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (47)

Show source-provided references
1. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 201910.1016/S2666-7568(21)00172-0 ↗
2. An overview and management of osteoporosis10.5152/eurjrheum.2016.048 ↗
3. Bone healing in 2016
4. Non-union bone fractures10.1038/s41572-021-00289-8 ↗
5. Morbidity at bone graft donor sites10.1097/00005131-198909000-00002 ↗
6. A review of the clinical side effects of bone morphogenetic protein-210.1089/ten.teb.2015.0357 ↗
7. Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds10.1016/j.biomaterials.2012.10.005 ↗
8. Controlled dual delivery of low doses of BMP-2 and VEGF in a silk fibroin–nanohydroxyapatite scaffold for vascularized bone regeneration10.1039/C7TB00949F ↗
9. Nanoscale coatings for ultralow dose BMP-2-driven regeneration of critical-sized bone defects10.1002/advs.201800361 ↗
10. Affinity-selected heparan sulfate for bone repair10.1016/j.biomaterials.2013.04.017 ↗
11. Repair of segmental ulna defects using a beta-TCP implant in combination with a heparan sulfate glycosaminoglycan variant10.1016/j.actbio.2015.09.008 ↗
12. A biomimetic collagen-bone granule-heparan sulfate combination scaffold for BMP2 delivery10.1016/j.gene.2020.145217 ↗
13. A polycaprolactone-β-tricalcium phosphate–heparan sulphate device for cranioplasty10.1016/j.jcms.2018.11.013 ↗
14. Fabrication of polycaprolactone-silanated β-tricalcium phosphate-heparan sulfate scaffolds for spinal fusion applications10.1016/j.spinee.2017.12.002 ↗
15. Application of a BMP2-binding heparan sulphate to promote periodontal regeneration10.22203/eCM.v042a10 ↗
16. Heparan sulfate proteoglycans: key mediators of stem cell function10.3389/fcell.2020.581213 ↗
17. The nature of the conserved basic amino acid sequences found among 437 heparin binding proteins determined by network analysis10.1039/C6MB00857G ↗
18. Demystifying heparan sulfate-protein interactions10.1146/annurev-biochem-060713-035314 ↗
19. Enhanced biological activity of BMP-2 bound to surface-grafted heparan sulfate10.1002/adbi.201600041 ↗
20. Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2)10.1016/j.bone.2011.12.013 ↗
21. Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells10.1074/jbc.M513414200 ↗
22. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-210.1074/jbc.M511039200 ↗
23. Minimum structural requirements for BMP-2-binding of heparin oligosaccharides10.1016/j.biomaterials.2018.08.056 ↗
24. Synthesis of 3-O-sulfated heparan sulfate oligosaccharides using 3-O-sulfotransferase isoform 410.1021/acschembio.1c00474 ↗
25. Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure10.1126/scitranslmed.aav8075 ↗
26. Modular synthesis of heparan sulfate oligosaccharides having N-acetyl and N-sulfate moieties10.1021/acs.joc.0c01881 ↗
27. Expedient synthesis of core disaccharide building blocks from natural polysaccharides for heparan sulfate oligosaccharide assembly10.1002/anie.201908805 ↗
28. Synthesis of heparan sulfate- and dermatan sulfate-related oligosaccharides via iterative chemoselective glycosylation exploiting conformationally disarmed [2.2.2] l-Iduronic lactone thioglycosides10.1021/acs.joc.9b01594 ↗
29. Making the longest sugars: a chemical synthesis of heparin-related [4] (n) oligosaccharides from 16-mer to 40-mer10.1039/C5SC02091C ↗
30. Tunable heparan sulfate mimetics for modulating chemokine activity10.1021/ja4027727 ↗
31. Glycocalyx remodeling with proteoglycan mimetics promotes neural specification in embryonic stem cells10.1021/ja505012a ↗
32. Dendrimer heparan sulfate glycomimetics: potent heparanase inhibitors for anticancer therapy10.1021/acschembio.8b00909 ↗
33. Synthesis of a targeted library of Heparan sulfate hexa- to dodecasaccharides as inhibitors of β-secretase: potential therapeutics for Alzheimer’s disease10.1002/chem.201204519 ↗
34. Single-entity heparan sulfate glycomimetic clusters for therapeutic applications10.1002/anie.201410251 ↗
35. Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization10.1091/mbc.e10-04-0348 ↗
36. Critical size bone defect healing using collagen–calcium phosphate bone graft materials10.1371/journal.pone.0168883 ↗
37. Variability in the composition of porcine mucosal heparan sulfates10.1016/j.carbpol.2021.119081 ↗
38. Potentiation of fibroblast growth factor activity by synthetic heparin oligosaccharide glycodendrimers10.1016/j.chembiol.2007.07.007 ↗
39. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin10.1073/pnas.77.11.6551 ↗
40. Anticoagulant heparin mimetics via RAFT polymerization10.1021/acs.biomac.9b01688 ↗
41. Sulfonated RAFT copolymers as heparin mimetics: synthesis, reactivity ratios, and anticoagulant activity10.1002/mabi.202000110 ↗
42. Microfluidic screening reveals heparan sulfate enhances human mesenchymal stem cell growth by modulating fibroblast growth factor-2 transport10.1002/sctm.16-0343 ↗
43. Synthesis of novel glycolipid mimetics of heparan sulfate and their application in colorectal cancer treatment in a mouse model10.1002/asia.202200228 ↗
44. A quartz crystal microbalance method to study the terminal functionalization of glycosaminoglycans10.1039/C4CC06905F ↗
45. Physical crosslinking of collagen fibers: comparison of ultraviolet irradiation and dehydrothermal treatment10.1002/jbm.820291108 ↗
46. Heterotopic bone formation by nano-apatite containing poly(D,L-lactide) composites10.22203/eCM.v019a24 ↗
47. Zinc in calcium phosphate mediates bone induction: in vitro and in vivo model10.1016/j.actbio.2013.10.011 ↗